Patient Square Capital Completes Acquisition of Premier

The latest update is out from Premier ( (PINC) ).

On November 25, 2025, Patient Square Capital completed its acquisition of Premier, Inc., valued at $2.6 billion. As a result of the merger, Premier’s common stock ceased trading and was delisted from Nasdaq. Shareholders received $28.25 per share in cash. The merger led to significant changes in Premier’s corporate structure, including the resignation of its board members and the amendment of its certificate of incorporation and bylaws. The company also initiated steps to terminate its registration and reporting obligations with the SEC.

The most recent analyst rating on (PINC) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on Premier stock, see the PINC Stock Forecast page.

Spark’s Take on PINC Stock

According to Spark, TipRanks’ AI Analyst, PINC is a Neutral.

Premier’s overall stock score is driven by strong earnings call results and positive technical indicators, despite challenges in financial performance and valuation concerns due to a negative P/E ratio. The company’s strategic initiatives and positive outlook for fiscal year 2026 provide additional support for the score.

To see Spark’s full report on PINC stock, click here.

More about Premier

Premier, Inc. is a leading technology-driven health care improvement company based in Charlotte, N.C. It plays a critical role in the health care industry by uniting providers, suppliers, payers, and policymakers to enhance health care through integrated data and analytics, collaboratives, supply chain solutions, consulting, and other services.

Average Trading Volume: 1,517,095

Technical Sentiment Signal: Buy

Current Market Cap: $2.34B

For detailed information about PINC stock, go to TipRanks’ Stock Analysis page.